Ayala Pharmaceuticals Preço/Valor Contábil
Qual é o Preço/Valor Contábil de Ayala Pharmaceuticals?
O Preço/Valor Contábil de Ayala Pharmaceuticals Inc. é 0.00
Qual é a definição de Preço/Valor Contábil?
A razão entre cotação e valor contabilístico representa a razão entre o valor das ações de uma empresa e o valor contábil por ação.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Preço/Valor Contábil de empresas na Setor Health Care em NASDAQ em comparação com Ayala Pharmaceuticals
O que Ayala Pharmaceuticals faz?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Empresas com preço/valor contábil semelhantes a Ayala Pharmaceuticals
- GBL Industries tem Preço/Valor Contábil de 0.00
- GoPro tem Preço/Valor Contábil de 0.00
- ams AG tem Preço/Valor Contábil de 0.00
- Taronis Fuels tem Preço/Valor Contábil de 0.00
- Bang & Olufsen a/s tem Preço/Valor Contábil de 0.00
- Noble plc tem Preço/Valor Contábil de 0.00
- Ayala Pharmaceuticals tem Preço/Valor Contábil de 0.00
- Montello Resources tem Preço/Valor Contábil de 0.00
- Unit tem Preço/Valor Contábil de 0.00
- Oasmia Pharmaceutical AB (publ) tem Preço/Valor Contábil de 0.00
- Chaparral tem Preço/Valor Contábil de 0.00
- Hi Crush Inc tem Preço/Valor Contábil de 0.00
- Savencia SA tem Preço/Valor Contábil de 0.00